Richard Bryan

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Research Cancer Research professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Sarah Pirrie

University of Birmingham

UNITED KINGDOM

View details

Robert Jones

University of Glasgow

UNITED KINGDOM

View details

Paul Toren

Assistant Professor

CANADA

View details

Matthew Sydes

University College London

UNITED KINGDOM

View details

Katja Aben

Radboud University Medical Center

NETHERLANDS

View details

Prashant Patel

Senior Lecturer

University of Birmingham

UNITED KINGDOM

View details

Lars Dyrskjøt

Aarhus University Hospital

DENMARK

View details

Typhaine GRIS

Professionnelle de recherche

Centre de recherche du CHU de Québec-Université Laval

CANADA

View details

Anna Wilkins

Institute of Cancer Research

UNITED KINGDOM

View details

Helen Parsons

Associate Professor

University of Warwick Warwick Medical School

UNITED KINGDOM

View details

Nicholas James

Professor of Prostate and Bladder Cancer Research

Institute of Cancer Research

UNITED KINGDOM

View details

james catto

Professor of Urological Surgery

University of Sheffield Medical School

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Richard Bryan

Research Interests

Explore related searches

Contact this professor

Articles (15)

Unlocking the potential of urine-based liquid biopsy through improved reporting and standardization

Improving the pathway to correct treatment for patients with muscle‐invasive bladder cancer: exploring the myths around the BladderPath trial

Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial

Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial

Making administrative healthcare systems clinical data the future of clinical trials: lessons from BladderPath

The sex gap in bladder cancer survival — a missing link in bladder cancer care?

Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action

Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial Carcinoma

Immunotherapy for non-muscle-invasive bladder cancer: from the origins of BCG to novel therapies

The Sirenic Links between Diabetes, Obesity, and Bladder Cancer

Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?

Establishing the Bladder Cancer Research Centre at the University of Birmingham

Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study

Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators

PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium

Collaborators (12)

Sarah Pirrie

Robert Jones

Paul Toren

Matthew Sydes

Katja Aben

Prashant Patel

Lars Dyrskjøt

Typhaine GRIS

Anna Wilkins

Helen Parsons

Nicholas James

james catto

Make your next move.